CN104502426B - 用于确定样品中的分析物浓度的方法 - Google Patents
用于确定样品中的分析物浓度的方法 Download PDFInfo
- Publication number
- CN104502426B CN104502426B CN201410799047.9A CN201410799047A CN104502426B CN 104502426 B CN104502426 B CN 104502426B CN 201410799047 A CN201410799047 A CN 201410799047A CN 104502426 B CN104502426 B CN 104502426B
- Authority
- CN
- China
- Prior art keywords
- sample
- underfill
- initial
- compensation
- analysis
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 238000012360 testing method Methods 0.000 claims abstract description 301
- 238000004458 analytical method Methods 0.000 claims abstract description 220
- 239000012491 analyte Substances 0.000 claims abstract description 146
- 230000004044 response Effects 0.000 claims abstract description 76
- 230000005284 excitation Effects 0.000 claims description 48
- 238000000034 method Methods 0.000 claims description 44
- 238000001514 detection method Methods 0.000 claims description 21
- 230000008859 change Effects 0.000 claims description 17
- 229920006395 saturated elastomer Polymers 0.000 claims description 12
- 241000208340 Araliaceae Species 0.000 claims description 4
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 claims description 4
- 235000003140 Panax quinquefolius Nutrition 0.000 claims description 4
- 235000008434 ginseng Nutrition 0.000 claims description 4
- 238000005259 measurement Methods 0.000 abstract description 75
- 230000006870 function Effects 0.000 description 250
- 238000003860 storage Methods 0.000 description 71
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 34
- 239000008103 glucose Substances 0.000 description 33
- 210000004027 cell Anatomy 0.000 description 30
- 101150025612 POLL gene Proteins 0.000 description 28
- 241000894007 species Species 0.000 description 26
- 210000004369 blood Anatomy 0.000 description 21
- 239000008280 blood Substances 0.000 description 20
- 239000000047 product Substances 0.000 description 20
- 238000005086 pumping Methods 0.000 description 17
- 239000013589 supplement Substances 0.000 description 17
- 238000006479 redox reaction Methods 0.000 description 15
- 239000003153 chemical reaction reagent Substances 0.000 description 14
- 238000004891 communication Methods 0.000 description 13
- 239000004020 conductor Substances 0.000 description 13
- 238000012546 transfer Methods 0.000 description 10
- 238000006722 reduction reaction Methods 0.000 description 9
- 238000004082 amperometric method Methods 0.000 description 8
- 230000009467 reduction Effects 0.000 description 8
- 230000006872 improvement Effects 0.000 description 6
- 230000002829 reductive effect Effects 0.000 description 6
- 108090000790 Enzymes Proteins 0.000 description 5
- 102000004190 Enzymes Human genes 0.000 description 5
- 230000008901 benefit Effects 0.000 description 5
- 238000003869 coulometry Methods 0.000 description 5
- 229940088598 enzyme Drugs 0.000 description 5
- 238000010606 normalization Methods 0.000 description 5
- 230000008569 process Effects 0.000 description 5
- 238000004832 voltammetry Methods 0.000 description 5
- BPYKTIZUTYGOLE-IFADSCNNSA-N Bilirubin Chemical compound N1C(=O)C(C)=C(C=C)\C1=C\C1=C(C)C(CCC(O)=O)=C(CC2=C(C(C)=C(\C=C/3C(=C(C=C)C(=O)N\3)C)N2)CCC(O)=O)N1 BPYKTIZUTYGOLE-IFADSCNNSA-N 0.000 description 4
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 4
- 238000010586 diagram Methods 0.000 description 4
- 238000005516 engineering process Methods 0.000 description 4
- 230000007613 environmental effect Effects 0.000 description 4
- 230000036541 health Effects 0.000 description 4
- 230000002427 irreversible effect Effects 0.000 description 4
- 239000000463 material Substances 0.000 description 4
- LEHOTFFKMJEONL-UHFFFAOYSA-N Uric Acid Chemical compound N1C(=O)NC(=O)C2=C1NC(=O)N2 LEHOTFFKMJEONL-UHFFFAOYSA-N 0.000 description 3
- TVWHNULVHGKJHS-UHFFFAOYSA-N Uric acid Natural products N1C(=O)NC(=O)C2NC(=O)NC21 TVWHNULVHGKJHS-UHFFFAOYSA-N 0.000 description 3
- 239000000853 adhesive Substances 0.000 description 3
- 230000001070 adhesive effect Effects 0.000 description 3
- 210000001367 artery Anatomy 0.000 description 3
- 230000000712 assembly Effects 0.000 description 3
- 238000000429 assembly Methods 0.000 description 3
- 239000003795 chemical substances by application Substances 0.000 description 3
- 230000007547 defect Effects 0.000 description 3
- 230000005611 electricity Effects 0.000 description 3
- 238000006056 electrooxidation reaction Methods 0.000 description 3
- 210000003743 erythrocyte Anatomy 0.000 description 3
- 150000002148 esters Chemical class 0.000 description 3
- 230000007717 exclusion Effects 0.000 description 3
- 230000002452 interceptive effect Effects 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 230000007246 mechanism Effects 0.000 description 3
- 230000003647 oxidation Effects 0.000 description 3
- 238000007254 oxidation reaction Methods 0.000 description 3
- 229920000642 polymer Polymers 0.000 description 3
- 238000004080 punching Methods 0.000 description 3
- 230000036632 reaction speed Effects 0.000 description 3
- 230000000306 recurrent effect Effects 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 239000000758 substrate Substances 0.000 description 3
- 230000007704 transition Effects 0.000 description 3
- 229940116269 uric acid Drugs 0.000 description 3
- 210000003462 vein Anatomy 0.000 description 3
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-M Lactate Chemical compound CC(O)C([O-])=O JVTAAEKCZFNVCJ-UHFFFAOYSA-M 0.000 description 2
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 2
- 229910052799 carbon Inorganic materials 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 235000012000 cholesterol Nutrition 0.000 description 2
- 150000004696 coordination complex Chemical class 0.000 description 2
- 238000012937 correction Methods 0.000 description 2
- 238000000151 deposition Methods 0.000 description 2
- 238000013461 design Methods 0.000 description 2
- 238000003745 diagnosis Methods 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 230000005518 electrochemistry Effects 0.000 description 2
- 230000002708 enhancing effect Effects 0.000 description 2
- 210000003722 extracellular fluid Anatomy 0.000 description 2
- 239000012530 fluid Substances 0.000 description 2
- 238000005534 hematocrit Methods 0.000 description 2
- 229910052738 indium Inorganic materials 0.000 description 2
- 210000002977 intracellular fluid Anatomy 0.000 description 2
- 150000002576 ketones Chemical class 0.000 description 2
- 239000011159 matrix material Substances 0.000 description 2
- 229910052751 metal Inorganic materials 0.000 description 2
- 239000002184 metal Substances 0.000 description 2
- 238000012544 monitoring process Methods 0.000 description 2
- COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 description 2
- 238000012545 processing Methods 0.000 description 2
- 210000003296 saliva Anatomy 0.000 description 2
- 238000011144 upstream manufacturing Methods 0.000 description 2
- 210000002700 urine Anatomy 0.000 description 2
- RZVAJINKPMORJF-UHFFFAOYSA-N Acetaminophen Chemical compound CC(=O)NC1=CC=C(O)C=C1 RZVAJINKPMORJF-UHFFFAOYSA-N 0.000 description 1
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Natural products OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 1
- 108010015776 Glucose oxidase Proteins 0.000 description 1
- 239000004366 Glucose oxidase Substances 0.000 description 1
- 108090000854 Oxidoreductases Proteins 0.000 description 1
- 102000004316 Oxidoreductases Human genes 0.000 description 1
- 108010076504 Protein Sorting Signals Proteins 0.000 description 1
- KJTLSVCANCCWHF-UHFFFAOYSA-N Ruthenium Chemical compound [Ru] KJTLSVCANCCWHF-UHFFFAOYSA-N 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- QGZKDVFQNNGYKY-UHFFFAOYSA-O ammonium group Chemical group [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 235000010323 ascorbic acid Nutrition 0.000 description 1
- 229960005070 ascorbic acid Drugs 0.000 description 1
- 239000011668 ascorbic acid Substances 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 239000013060 biological fluid Substances 0.000 description 1
- 230000003139 buffering effect Effects 0.000 description 1
- 230000002301 combined effect Effects 0.000 description 1
- 239000002322 conducting polymer Substances 0.000 description 1
- 229920001940 conductive polymer Polymers 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000006866 deterioration Effects 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 229910003460 diamond Inorganic materials 0.000 description 1
- 239000010432 diamond Substances 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 239000004744 fabric Substances 0.000 description 1
- -1 free fatty Chemical compound 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 229940116332 glucose oxidase Drugs 0.000 description 1
- 235000019420 glucose oxidase Nutrition 0.000 description 1
- 125000002791 glucosyl group Chemical group C1([C@H](O)[C@@H](O)[C@H](O)[C@H](O1)CO)* 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- 230000006698 induction Effects 0.000 description 1
- 238000013101 initial test Methods 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- PANJMBIFGCKWBY-UHFFFAOYSA-N iron tricyanide Chemical compound N#C[Fe](C#N)C#N PANJMBIFGCKWBY-UHFFFAOYSA-N 0.000 description 1
- TYQCGQRIZGCHNB-JLAZNSOCSA-N l-ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(O)=C(O)C1=O TYQCGQRIZGCHNB-JLAZNSOCSA-N 0.000 description 1
- 238000012886 linear function Methods 0.000 description 1
- 239000003550 marker Substances 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 238000001208 nuclear magnetic resonance pulse sequence Methods 0.000 description 1
- 230000033116 oxidation-reduction process Effects 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 229960005489 paracetamol Drugs 0.000 description 1
- 230000032696 parturition Effects 0.000 description 1
- 210000002381 plasma Anatomy 0.000 description 1
- 238000004313 potentiometry Methods 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 239000000700 radioactive tracer Substances 0.000 description 1
- 230000035484 reaction time Effects 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000002441 reversible effect Effects 0.000 description 1
- 229910052707 ruthenium Inorganic materials 0.000 description 1
- 239000013049 sediment Substances 0.000 description 1
- 239000004065 semiconductor Substances 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 238000007493 shaping process Methods 0.000 description 1
- 238000004088 simulation Methods 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 238000007619 statistical method Methods 0.000 description 1
- 230000001502 supplementing effect Effects 0.000 description 1
- 230000009897 systematic effect Effects 0.000 description 1
- 150000003626 triacylglycerols Chemical class 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N27/00—Investigating or analysing materials by the use of electric, electrochemical, or magnetic means
- G01N27/26—Investigating or analysing materials by the use of electric, electrochemical, or magnetic means by investigating electrochemical variables; by using electrolysis or electrophoresis
- G01N27/416—Systems
- G01N27/4163—Systems checking the operation of, or calibrating, the measuring apparatus
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/483—Physical analysis of biological material
- G01N33/487—Physical analysis of biological material of liquid biological material
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N27/00—Investigating or analysing materials by the use of electric, electrochemical, or magnetic means
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N27/00—Investigating or analysing materials by the use of electric, electrochemical, or magnetic means
- G01N27/26—Investigating or analysing materials by the use of electric, electrochemical, or magnetic means by investigating electrochemical variables; by using electrolysis or electrophoresis
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N27/00—Investigating or analysing materials by the use of electric, electrochemical, or magnetic means
- G01N27/26—Investigating or analysing materials by the use of electric, electrochemical, or magnetic means by investigating electrochemical variables; by using electrolysis or electrophoresis
- G01N27/28—Electrolytic cell components
- G01N27/30—Electrodes, e.g. test electrodes; Half-cells
- G01N27/327—Biochemical electrodes, e.g. electrical or mechanical details for in vitro measurements
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N27/00—Investigating or analysing materials by the use of electric, electrochemical, or magnetic means
- G01N27/26—Investigating or analysing materials by the use of electric, electrochemical, or magnetic means by investigating electrochemical variables; by using electrolysis or electrophoresis
- G01N27/28—Electrolytic cell components
- G01N27/30—Electrodes, e.g. test electrodes; Half-cells
- G01N27/327—Biochemical electrodes, e.g. electrical or mechanical details for in vitro measurements
- G01N27/3271—Amperometric enzyme electrodes for analytes in body fluids, e.g. glucose in blood
- G01N27/3274—Corrective measures, e.g. error detection, compensation for temperature or hematocrit, calibration
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/483—Physical analysis of biological material
- G01N33/487—Physical analysis of biological material of liquid biological material
- G01N33/4875—Details of handling test elements, e.g. dispensing or storage, not specific to a particular test method
- G01N33/48771—Coding of information, e.g. calibration data, lot number
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Immunology (AREA)
- Pathology (AREA)
- Electrochemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Molecular Biology (AREA)
- Hematology (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Biophysics (AREA)
- Urology & Nephrology (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Investigating Or Analyzing Materials By The Use Of Electric Means (AREA)
- Measurement Of The Respiration, Hearing Ability, Form, And Blood Characteristics Of Living Organisms (AREA)
- Investigating Or Analysing Materials By Optical Means (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US35223410P | 2010-06-07 | 2010-06-07 | |
| US61/352,234 | 2010-06-07 | ||
| CN201180028354.1A CN103038636B (zh) | 2010-06-07 | 2011-06-07 | 用于生物传感器的未充满管理系统 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201180028354.1A Division CN103038636B (zh) | 2010-06-07 | 2011-06-07 | 用于生物传感器的未充满管理系统 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN104502426A CN104502426A (zh) | 2015-04-08 |
| CN104502426B true CN104502426B (zh) | 2017-05-10 |
Family
ID=44583361
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201410799047.9A Active CN104502426B (zh) | 2010-06-07 | 2011-06-07 | 用于确定样品中的分析物浓度的方法 |
| CN201180028354.1A Active CN103038636B (zh) | 2010-06-07 | 2011-06-07 | 用于生物传感器的未充满管理系统 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201180028354.1A Active CN103038636B (zh) | 2010-06-07 | 2011-06-07 | 用于生物传感器的未充满管理系统 |
Country Status (10)
| Country | Link |
|---|---|
| US (2) | US9222910B2 (enExample) |
| EP (1) | EP2577303B1 (enExample) |
| JP (1) | JP5856155B2 (enExample) |
| KR (1) | KR101929058B1 (enExample) |
| CN (2) | CN104502426B (enExample) |
| BR (1) | BR112012031375A2 (enExample) |
| CA (2) | CA3047242A1 (enExample) |
| MX (2) | MX367439B (enExample) |
| RU (1) | RU2566382C2 (enExample) |
| WO (1) | WO2011156325A2 (enExample) |
Families Citing this family (36)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2096437B1 (en) * | 2000-11-30 | 2014-11-19 | Panasonic Healthcare Co., Ltd. | Biosensor for quantifying substrate |
| US7966859B2 (en) | 2006-05-03 | 2011-06-28 | Bayer Healthcare Llc | Underfill detection system for a biosensor |
| WO2012114706A1 (ja) * | 2011-02-23 | 2012-08-30 | パナソニック株式会社 | 生体試料測定装置 |
| US8840776B2 (en) * | 2011-10-25 | 2014-09-23 | Bionime Corporation | Method and sensor strip for analysis of a sample |
| JP5749806B2 (ja) * | 2011-11-01 | 2015-07-15 | パナソニックヘルスケアホールディングス株式会社 | 生体試料測定装置 |
| US9903830B2 (en) | 2011-12-29 | 2018-02-27 | Lifescan Scotland Limited | Accurate analyte measurements for electrochemical test strip based on sensed physical characteristic(s) of the sample containing the analyte |
| US8877023B2 (en) * | 2012-06-21 | 2014-11-04 | Lifescan Scotland Limited | Electrochemical-based analytical test strip with intersecting sample-receiving chambers |
| US9005426B2 (en) * | 2012-09-28 | 2015-04-14 | Cilag Gmbh International | System and method for determining hematocrit insensitive glucose concentration |
| US9080196B2 (en) | 2012-09-28 | 2015-07-14 | Cilag Gmbh International | System and method for determining hematocrit insensitive glucose concentration |
| US8926369B2 (en) * | 2012-12-20 | 2015-01-06 | Lifescan Scotland Limited | Electrical connector for substrate having conductive tracks |
| TWI493186B (zh) * | 2013-02-08 | 2015-07-21 | Hmd Biomedical Inc | 檢測試片、檢測裝置及檢測方法 |
| US9157883B2 (en) | 2013-03-07 | 2015-10-13 | Lifescan Scotland Limited | Methods and systems to determine fill direction and fill error in analyte measurements |
| CN103412012B (zh) * | 2013-03-28 | 2015-09-09 | 利多(香港)有限公司 | 生物传感器 |
| US9435762B2 (en) * | 2013-06-27 | 2016-09-06 | Lifescan Scotland Limited | Fill error trap for an analyte measurement determined from a specified sampling time derived from a sensed physical characteristic of the sample containing the analyte |
| US9738916B2 (en) | 2013-07-08 | 2017-08-22 | Panasonic Healthcare Holdings Co., Ltd. | Blood component measurement device and blood component measurement method |
| CN104345079A (zh) * | 2013-08-02 | 2015-02-11 | 达尔生技股份有限公司 | 判断方法 |
| US9243276B2 (en) | 2013-08-29 | 2016-01-26 | Lifescan Scotland Limited | Method and system to determine hematocrit-insensitive glucose values in a fluid sample |
| US9459231B2 (en) | 2013-08-29 | 2016-10-04 | Lifescan Scotland Limited | Method and system to determine erroneous measurement signals during a test measurement sequence |
| EP3216076B1 (en) * | 2014-11-03 | 2024-03-06 | F. Hoffmann-La Roche AG | Method of using electrochemical test elements having multiple electrode arrangements |
| CN104792832A (zh) * | 2015-04-16 | 2015-07-22 | 三诺生物传感股份有限公司 | 一种胆红素电化学传感器及其制备方法 |
| CN106226379A (zh) * | 2016-07-10 | 2016-12-14 | 浙江亿联健医疗器械有限公司 | 一种消除进样过程影响的生物传感器及测试方法 |
| EP3485265B1 (en) | 2016-07-12 | 2025-03-12 | Ascensia Diabetes Care Holdings AG | Method for electrochemical analysis by use of alternating output signals from two electrodes |
| ES2856174T3 (es) * | 2016-09-07 | 2021-09-27 | Hoffmann La Roche | Procedimientos para someter a prueba sensores electroquímicos basados en enzimas |
| WO2018104835A1 (en) * | 2016-12-05 | 2018-06-14 | Ascensia Diabetes Care Holdings Ag | Risk factor monitoring |
| EP3618712A1 (en) * | 2017-05-03 | 2020-03-11 | Abbott Diabetes Care Inc. | Systems, devices, and methods with duration-based adjustment of sensor data |
| JP6876157B2 (ja) * | 2017-07-03 | 2021-05-26 | エフ ホフマン−ラ ロッシュ アクチェン ゲゼルシャフト | バイオセンサの生体内特性を検出する方法および電子ユニット |
| EP3713477B1 (en) | 2017-11-21 | 2022-07-06 | MX3 Diagnostics, Inc. | Saliva testing system and method |
| WO2020032957A1 (en) * | 2018-08-09 | 2020-02-13 | Hewlett-Packard Development Company, L.P. | Microfluidic devices to detect fluid priming |
| CN109884150B (zh) * | 2019-03-08 | 2021-05-14 | 武汉璟泓科技股份有限公司 | 一种红细胞积压校正方法及存储介质 |
| US11701036B2 (en) | 2019-07-10 | 2023-07-18 | MX3 Diagnostics, Inc. | Saliva test strip and method |
| WO2021154846A1 (en) * | 2020-01-30 | 2021-08-05 | MX3 Diagnostics, Inc. | Biological fluid sample assessment |
| JP7752879B2 (ja) * | 2020-09-28 | 2025-10-14 | ドンウン アナテック カンパニー リミテッド | 検体測定のためのバイオセンサ構造およびこれを利用した検体測定方法 |
| JP7576528B2 (ja) * | 2021-09-16 | 2024-10-31 | アークレイ株式会社 | 測定方法及び測定装置 |
| CN115021836B (zh) * | 2022-05-31 | 2024-09-24 | 哲库科技(北京)有限公司 | 信号补偿方法及装置、频域补偿数据确定方法及装置 |
| CN115081949B (zh) * | 2022-07-28 | 2022-11-08 | 深圳赛桥生物创新技术有限公司 | 进样体积可调的样品工艺操作方法、装置、设备及介质 |
| CN119643645B (zh) * | 2025-02-18 | 2025-06-20 | 三诺生物传感股份有限公司 | 一种试条吸满判断方法 |
Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101297196A (zh) * | 2005-07-20 | 2008-10-29 | 拜尔健康护理有限责任公司 | 门控电流分析法 |
| CN101374455A (zh) * | 2006-02-27 | 2009-02-25 | 拜尔健康护理有限责任公司 | 用于生物传感器系统的温度调节的分析物测定 |
| CN101432620A (zh) * | 2006-05-03 | 2009-05-13 | 拜尔健康护理有限责任公司 | 用于电化学生物传感器的未足量检测系统 |
| TW200933147A (en) * | 2007-12-10 | 2009-08-01 | Bayer Healthcare Llc | Slope-based compensation |
Family Cites Families (43)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4431004A (en) | 1981-10-27 | 1984-02-14 | Bessman Samuel P | Implantable glucose sensor |
| US5352351A (en) | 1993-06-08 | 1994-10-04 | Boehringer Mannheim Corporation | Biosensing meter with fail/safe procedures to prevent erroneous indications |
| US6153069A (en) | 1995-02-09 | 2000-11-28 | Tall Oak Ventures | Apparatus for amperometric Diagnostic analysis |
| US5582697A (en) | 1995-03-17 | 1996-12-10 | Matsushita Electric Industrial Co., Ltd. | Biosensor, and a method and a device for quantifying a substrate in a sample liquid using the same |
| US5620579A (en) | 1995-05-05 | 1997-04-15 | Bayer Corporation | Apparatus for reduction of bias in amperometric sensors |
| ATE227844T1 (de) | 1997-02-06 | 2002-11-15 | Therasense Inc | Kleinvolumiger sensor zur in-vitro bestimmung |
| US6391645B1 (en) | 1997-05-12 | 2002-05-21 | Bayer Corporation | Method and apparatus for correcting ambient temperature effect in biosensors |
| HU222809B1 (hu) | 1997-10-03 | 2003-10-28 | 77 Elektronika Műszeripari Kft. | Eljárás és készülék kémiai összetevőnek anyagmintából, különösen vér glükóztartalmának vérmintából történő meghatározásához |
| CA2311487C (en) | 1998-05-13 | 2004-02-10 | Cygnus, Inc. | Signal processing for measurement of physiological analytes |
| JP4256588B2 (ja) | 1998-05-20 | 2009-04-22 | アークレイ株式会社 | 統計的手法を用いた電気化学的測定方法および測定装置 |
| CA2305922C (en) | 1999-08-02 | 2005-09-20 | Bayer Corporation | Improved electrochemical sensor design |
| US6616819B1 (en) | 1999-11-04 | 2003-09-09 | Therasense, Inc. | Small volume in vitro analyte sensor and methods |
| US7351323B2 (en) | 2001-01-17 | 2008-04-01 | Arkray, Inc. | Quantitative analyzing method and quantitative analyzer using sensor |
| US6541266B2 (en) | 2001-02-28 | 2003-04-01 | Home Diagnostics, Inc. | Method for determining concentration of an analyte in a test strip |
| US6562625B2 (en) | 2001-02-28 | 2003-05-13 | Home Diagnostics, Inc. | Distinguishing test types through spectral analysis |
| AU784254B2 (en) | 2001-05-21 | 2006-03-02 | Bayer Corporation | Improved electrochemical sensor |
| US6797150B2 (en) | 2001-10-10 | 2004-09-28 | Lifescan, Inc. | Determination of sample volume adequacy in biosensor devices |
| WO2003034055A1 (en) | 2001-10-12 | 2003-04-24 | Arkray, Inc. | Concentration measuring method and concentration measuring device |
| US6872298B2 (en) * | 2001-11-20 | 2005-03-29 | Lifescan, Inc. | Determination of sample volume adequacy in biosensor devices |
| CA2419213C (en) | 2002-03-07 | 2011-06-21 | Bayer Healthcare Llc | Improved electrical sensor |
| US6964871B2 (en) | 2002-04-25 | 2005-11-15 | Home Diagnostics, Inc. | Systems and methods for blood glucose sensing |
| US6946299B2 (en) | 2002-04-25 | 2005-09-20 | Home Diagnostics, Inc. | Systems and methods for blood glucose sensing |
| US6743635B2 (en) * | 2002-04-25 | 2004-06-01 | Home Diagnostics, Inc. | System and methods for blood glucose sensing |
| EP2149792B1 (en) | 2002-07-25 | 2017-01-25 | ARKRAY, Inc. | Sample analyzing method |
| DE60220288T2 (de) * | 2002-11-21 | 2008-01-17 | Lifescan, Inc., Milpitas | Bestimmung der Genauigkeit eines Probevolumens in Biosensoren |
| US7132041B2 (en) * | 2003-02-11 | 2006-11-07 | Bayer Healthcare Llc | Methods of determining the concentration of an analyte in a fluid test sample |
| US7452457B2 (en) | 2003-06-20 | 2008-11-18 | Roche Diagnostics Operations, Inc. | System and method for analyte measurement using dose sufficiency electrodes |
| US7488601B2 (en) | 2003-06-20 | 2009-02-10 | Roche Diagnostic Operations, Inc. | System and method for determining an abused sensor during analyte measurement |
| JP4814110B2 (ja) | 2004-02-06 | 2011-11-16 | バイエル・ヘルスケア・エルエルシー | 電気化学的バイオセンサ |
| BRPI0512170A (pt) * | 2004-06-17 | 2008-02-12 | Bayer Healthcare Llc | detectando preenchimento incompleto de biosensores |
| GB0501826D0 (en) | 2005-01-28 | 2005-03-09 | Melys Diagnostics Ltd | Apparatus for measurement of analyte concentration |
| US20090067150A1 (en) | 2005-03-22 | 2009-03-12 | Tomoaki Ito | Protection Film for Preventing Leakage of Information, Portable Pouch, Card Case, and Information-Leakage Preventing Plate |
| RU2453843C2 (ru) | 2005-04-08 | 2012-06-20 | Байер Хелткэр Ллк | Окисляемые виды соединений в качестве внутреннего стандарта в контрольных растворах для биосенсоров |
| BRPI0613592A2 (pt) | 2005-07-20 | 2011-01-18 | Bayer Healthcare Llc | amperometria conectada por porta |
| WO2007040913A1 (en) | 2005-09-30 | 2007-04-12 | Bayer Healthcare Llc | Gated voltammetry |
| DE202005020335U1 (de) | 2005-12-28 | 2006-05-11 | Health & Life Co., Ltd., Chung-Ho | Biosensor mit einem Mikrokanal zur gleichzeitigen Bestimmung von mehreren biochemischen Stoffen |
| US7966859B2 (en) | 2006-05-03 | 2011-06-28 | Bayer Healthcare Llc | Underfill detection system for a biosensor |
| RU2465812C2 (ru) * | 2006-05-08 | 2012-11-10 | БАЙЕР ХЕЛТКЭА ЭлЭлСи | Система детектирования аномального выходного сигнала для биосенсора |
| US7771583B2 (en) | 2006-10-18 | 2010-08-10 | Agamatrix, Inc. | Electrochemical determination of analytes |
| US20110029318A1 (en) | 2008-06-16 | 2011-02-03 | Anna Pucar Rimhagen | Global operator license prioritizing and distribution |
| WO2010077660A1 (en) | 2008-12-08 | 2010-07-08 | Bayer Healthcare Llc | Biosensor system with signal adjustment |
| BR112012009291A2 (pt) | 2009-11-10 | 2016-05-31 | Bayer Healthcare Llc | sistema de reconhecimento de subenchimento para um biossensor |
| MX2012010860A (es) * | 2010-03-22 | 2013-03-05 | Bayer Healthcare Llc | Compensacion residual para un biosensor. |
-
2011
- 2011-06-07 BR BR112012031375A patent/BR112012031375A2/pt not_active IP Right Cessation
- 2011-06-07 JP JP2013514282A patent/JP5856155B2/ja active Active
- 2011-06-07 MX MX2016007498A patent/MX367439B/es unknown
- 2011-06-07 KR KR1020137000325A patent/KR101929058B1/ko active Active
- 2011-06-07 CN CN201410799047.9A patent/CN104502426B/zh active Active
- 2011-06-07 WO PCT/US2011/039382 patent/WO2011156325A2/en not_active Ceased
- 2011-06-07 US US13/154,650 patent/US9222910B2/en active Active
- 2011-06-07 EP EP11752665.7A patent/EP2577303B1/en active Active
- 2011-06-07 MX MX2012014281A patent/MX339815B/es active IP Right Grant
- 2011-06-07 CA CA3047242A patent/CA3047242A1/en not_active Abandoned
- 2011-06-07 CN CN201180028354.1A patent/CN103038636B/zh active Active
- 2011-06-07 RU RU2012158102/28A patent/RU2566382C2/ru active
- 2011-06-07 CA CA2798031A patent/CA2798031C/en not_active Expired - Fee Related
-
2015
- 2015-11-19 US US14/946,570 patent/US10175194B2/en active Active
Patent Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101297196A (zh) * | 2005-07-20 | 2008-10-29 | 拜尔健康护理有限责任公司 | 门控电流分析法 |
| CN101374455A (zh) * | 2006-02-27 | 2009-02-25 | 拜尔健康护理有限责任公司 | 用于生物传感器系统的温度调节的分析物测定 |
| CN101432620A (zh) * | 2006-05-03 | 2009-05-13 | 拜尔健康护理有限责任公司 | 用于电化学生物传感器的未足量检测系统 |
| TW200933147A (en) * | 2007-12-10 | 2009-08-01 | Bayer Healthcare Llc | Slope-based compensation |
Also Published As
| Publication number | Publication date |
|---|---|
| US20110297557A1 (en) | 2011-12-08 |
| US20160077050A1 (en) | 2016-03-17 |
| CA2798031C (en) | 2019-08-20 |
| KR101929058B1 (ko) | 2018-12-13 |
| CN104502426A (zh) | 2015-04-08 |
| US9222910B2 (en) | 2015-12-29 |
| RU2012158102A (ru) | 2014-07-20 |
| RU2566382C2 (ru) | 2015-10-27 |
| BR112012031375A2 (pt) | 2016-10-25 |
| EP2577303B1 (en) | 2022-08-03 |
| CA2798031A1 (en) | 2011-12-15 |
| CA3047242A1 (en) | 2011-12-15 |
| JP5856155B2 (ja) | 2016-02-09 |
| US10175194B2 (en) | 2019-01-08 |
| KR20130109087A (ko) | 2013-10-07 |
| WO2011156325A2 (en) | 2011-12-15 |
| CN103038636A (zh) | 2013-04-10 |
| MX367439B (es) | 2019-08-22 |
| HK1206813A1 (en) | 2016-01-15 |
| EP2577303A2 (en) | 2013-04-10 |
| HK1178253A1 (en) | 2013-09-06 |
| CN103038636B (zh) | 2015-01-14 |
| MX339815B (es) | 2016-06-13 |
| MX2012014281A (es) | 2013-01-24 |
| JP2013531792A (ja) | 2013-08-08 |
| WO2011156325A3 (en) | 2012-03-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN104502426B (zh) | 用于确定样品中的分析物浓度的方法 | |
| US11988626B2 (en) | Residual compensation including underfill error | |
| KR101386992B1 (ko) | 분석대상물 농도의 판별을 위한 방법 및 관련된 장치 | |
| AU2015242942B2 (en) | Fill sufficiency method and system | |
| CN103210310B (zh) | 包含次级输出信号的基于斜率的补偿 | |
| CA2794978C (en) | Analyte measurement method and system | |
| EP2634572A2 (en) | Glucose measurement method and system | |
| AU2013322545B2 (en) | System and method for determining hematocrit insensitive glucose concentrations | |
| KR20130009975A (ko) | 전기화학적 분석에서의 커패시턴스 검출 | |
| EP2900138B1 (en) | System and method for determining hematocrit insensitive glucose concentration | |
| HK1178253B (en) | Underfill management system for a biosensor | |
| HK1206813B (en) | Method for determining analyte concentration in a sample | |
| HK1157866A (en) | Fill sufficiency method and system | |
| HK1177260B (en) | Residual compensation for a biosensor |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| REG | Reference to a national code |
Ref country code: HK Ref legal event code: DE Ref document number: 1206813 Country of ref document: HK |
|
| C41 | Transfer of patent application or patent right or utility model | ||
| TA01 | Transfer of patent application right |
Effective date of registration: 20160926 Address after: Basel Applicant after: BAYER HEALTHCARE LLC Address before: new jersey Applicant before: Bayer Corp. |
|
| GR01 | Patent grant | ||
| GR01 | Patent grant | ||
| REG | Reference to a national code |
Ref country code: HK Ref legal event code: GR Ref document number: 1206813 Country of ref document: HK |